Home » Third Circuit Revives Suit Against GSK Over Avandia Injury Costs
Third Circuit Revives Suit Against GSK Over Avandia Injury Costs
The Third Circuit on Thursday revived a proposed class action from two Humana units seeking reimbursement from GlaxoSmithKline for costs borne by the insurers for treatment of Medicare patients harmed by the diabetes drug Avandia.
Law360
Law360
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May